Literature DB >> 11165099

Potential use of gelcasting hydroxyapatite porous ceramic as an implantable drug delivery system.

D J Netz1, P Sepulveda, V C Pandolfelli, A C Spadaro, J B Alencastre, M V Bentley, J M Marchetti.   

Abstract

Hydroxyapatite (HA) ceramic in a porous configuration is suggested as a drug release system. A new technique for the production of this material, based on the foaming of suspensions and in situ polymerization (gelcasting method), resulted in a material whose characteristics are likely to make it useful as an implantable drug delivery system. Three batches of HA ceramic with different porosities were characterized by X-ray diffraction and scanning electron microscopy (SEM). Pore size and shape as well as density were determined. In vitro experiments were performed in order to evaluate the dissolution behavior of cisplatin in the system. X-ray diffraction analysis showed that the final product consisted of a single phase, indicating that the sintering process had not affected the structure of the HA. Energy dispersive X-ray analysis (EDX) showed absence of impurities. Pore diameters were in the range 15--34 microm. SEM showed that the material presented a highly interconnected spheroidal porous network with open micropores and closed macropores. In vitro experiments showed significant differences in the release rate of cisplatin between three different porosities.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11165099     DOI: 10.1016/s0378-5173(00)00659-1

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  Synthesis and characterization of collagen/hydroxyapatite: magnetite composite material for bone cancer treatment.

Authors:  Ecaterina Andronescu; Maria Ficai; Georgeta Voicu; Denisa Ficai; Maria Maganu; Anton Ficai
Journal:  J Mater Sci Mater Med       Date:  2010-04-07       Impact factor: 3.896

2.  A ceramic-based anticancer drug delivery system to treat breast cancer.

Authors:  Ahmed El-Ghannam; Krista Ricci; Ahmed Malkawi; Kiarash Jahed; Kumar Vedantham; Heather Wyan; Lauren D Allen; Didier Dréau
Journal:  J Mater Sci Mater Med       Date:  2010-07-20       Impact factor: 3.896

3.  Fabrication of porous bioceramics with porosity gradients similar to the bimodal structure of cortical and cancellous bone.

Authors:  Y H Hsu; I G Turner; A W Miles
Journal:  J Mater Sci Mater Med       Date:  2007-06-12       Impact factor: 3.896

4.  Development of new localized drug delivery system based on ceftriaxone-sulbactam composite drug impregnated porous hydroxyapatite: a systematic approach for in vitro and in vivo animal trial.

Authors:  Biswanath Kundu; Chidambaram Soundrapandian; Samit K Nandi; Prasenjit Mukherjee; Nandadulal Dandapat; Subhasis Roy; Bakul K Datta; Tapan K Mandal; Debabrata Basu; Rupnarayan N Bhattacharya
Journal:  Pharm Res       Date:  2010-05-13       Impact factor: 4.200

5.  Hydroxyapatite ceramics as a particulate embolic material: report of the clinical experience.

Authors:  Michiya Kubo; Naoya Kuwayama; Yutaka Hirashima; Akira Takaku; Tetsuro Ogawa; Shunro Endo
Journal:  AJNR Am J Neuroradiol       Date:  2003-09       Impact factor: 3.825

Review 6.  Multifunctional materials for bone cancer treatment.

Authors:  Catarina Marques; José M F Ferreira; Ecaterina Andronescu; Denisa Ficai; Maria Sonmez; Anton Ficai
Journal:  Int J Nanomedicine       Date:  2014-05-28

7.  In vivo ciprofloxacin release from hydroxyapatite-based bone implants in rabbit tibia: a preliminary study.

Authors:  Amit Kumar Nayak; Ajoy Bhattacharyya; Kalyan Kumar Sen
Journal:  ISRN Orthop       Date:  2011-12-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.